InvestorsHub Logo
Followers 54
Posts 1662
Boards Moderated 0
Alias Born 04/22/2022

Re: exwannabe post# 658899

Sunday, 12/24/2023 12:43:45 PM

Sunday, December 24, 2023 12:43:45 PM

Post# of 701423
ex,

You raise an excellent point!

I agree—with so many solid tumor cancers, the DCVax-L cell-based platform technology will be studied well into the future. Keytruda is the perfect example of this—Pembrolizumab is a blockbuster drug and has been included in many more clinical trials for years following its original approval and commercialization so many years ago!

Combo is King!

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html

Bullish
Bullish

Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News